Our team is eager to learn, driven and passionate. We are humble and fun.
Olivier joined Astorg in 2015 and is a member of the Investment Team.
Prior to this, Olivier worked for three years in the infrastructure investment division of 3I.
He started his career at Barclays Infrastructure Funds in 2012.
Olivier is a graduate civil engineer from Ecole Polytechnique and Ecole Nationale des Ponts et Chaussées in Paris and holds a Master of Science in Economics for the Paris School of Economics.
Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.
Investment year: 2021
Sustainable development goals:
ERT offers a compelling combination of technology, services and clinical expertise, helping their customers to deliver successful clinical trial outcomes.
Investment year: 2020
Echosens is a specialized diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases.
Investment year: 2018
HRA is an innovative OTC pharma company with leading positions in Europe and in the US.
Investment year: 2016